FDA Class II Device Recall: GEM Premier 5000
Summary
The FDA has initiated a Class II device recall (Z-1542-2026) for Instrumentation Laboratory's GEM Premier 5000 due to customer complaints of Process Control Solution Not Detected errors. The recall impacts worldwide distribution, including the US.
What changed
The FDA has classified a Class II device recall (Z-1542-2026) concerning Instrumentation Laboratory's GEM Premier 5000, part number 00055445008. The recall is due to confirmed customer complaints indicating an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during warm-up, which can lead to GEM PAK ejection and require re-insertion. This issue affects the reliability and potentially the accuracy of patient results.
This recall is ongoing and has worldwide distribution, including the United States and several other countries. Healthcare providers and facilities using the GEM Premier 5000 should be aware of this recall and review their internal procedures for managing device errors and cartridge replacements. While the document does not specify a compliance deadline, entities in possession of affected devices should consult Instrumentation Laboratory's recall instructions and the FDA's enforcement database for further guidance on remediation and reporting requirements.
What to do next
- Review internal procedures for managing GEM Premier 5000 PCSND errors and GEM PAK ejections.
- Consult Instrumentation Laboratory's recall instructions for remediation steps.
- Monitor FDA enforcement database for updates on recall status.
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1542-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Part No. 00055445008.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.